Influence of Antithrombotic Medication on the Risk of Chronic Subdural Hematoma Recurrence after Burr-Hole Surgery
| Autor: | Jinsu Pyen, Jongyeon Kim, Youn Moo Koo, Sung Min Cho, Kum Whang, Jong Wook Choi |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
030218 nuclear medicine & medical imaging 03 medical and health sciences 0302 clinical medicine Hematoma Recurrence Platelet aggregation inhibitors Antithrombotic medicine Risk factor Univariate analysis Clinical Article business.industry General Neuroscience Medical record Anticoagulants Odds ratio medicine.disease Confidence interval Surgery Hematoma Subdural Chronic Platelet aggregation inhibitor Neurology (clinical) business Neurotrauma 030217 neurology & neurosurgery |
| Zdroj: | Journal of Korean Neurosurgical Society |
| ISSN: | 1598-7876 2005-3711 |
| DOI: | 10.3340/jkns.2019.0194 |
| Popis: | Objective Chronic subdural hematoma (CSDH) is one of the most common intracranial hemorrhages. It can be managed with a simple surgical treatment such as burr-hole trephination and drainage. However, it has a relatively high recurrence rate. The mechanisms and risk factors for the recurrence have not yet been clearly identified and studies have reported varying results. Methods We analyzed 230 patients with CSDH who were treated with burr-hole trephination and drainage at our institution from March 2011 to March 2016. The patients were divided into recurrence and non-recurrence groups and the medical records of each group were used to analyze the risk factors associated with CSDH recurrence. Results After burr-hole trephination and drainage, CSDH recurrence was observed in 49 (21.3%) of the 230 patients. In univariate analysis, none of the factors showed statistical significance with respect to CSDH recurrence. In multivariate analysis, preoperative antithrombotic medication was the only independent risk factor for CSDH recurrence (odds ratio, 2.407; 95% confidence interval, 1.047-5.531). Conclusion The present study found that preoperative antithrombotic medication was independently associated with CSDH recurrence. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|